Fortress Biotech Inc (FBIO)
1.94
+0.18
(+10.23%)
USD |
NASDAQ |
May 17, 16:00
1.92
-0.02
(-1.03%)
After-Hours: 07:07
Fortress Biotech Free Cash Flow (Quarterly): -25.39M for March 31, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -25.39M |
December 31, 2023 | -35.00M |
September 30, 2023 | -17.78M |
June 30, 2023 | -40.32M |
March 31, 2023 | -43.22M |
December 31, 2022 | -28.24M |
September 30, 2022 | -44.29M |
June 30, 2022 | -61.73M |
March 31, 2022 | -48.20M |
December 31, 2021 | -42.20M |
September 30, 2021 | -29.24M |
June 30, 2021 | -39.30M |
March 31, 2021 | -22.15M |
December 31, 2020 | -22.05M |
September 30, 2020 | -26.65M |
June 30, 2020 | -18.48M |
March 31, 2020 | -23.67M |
December 31, 2019 | -29.74M |
September 30, 2019 | -20.01M |
June 30, 2019 | -28.98M |
March 31, 2019 | -25.62M |
December 31, 2018 | -23.70M |
September 30, 2018 | -27.89M |
June 30, 2018 | -27.93M |
March 31, 2018 | -28.68M |
Date | Value |
---|---|
December 31, 2017 | -22.91M |
September 30, 2017 | -25.93M |
June 30, 2017 | -24.08M |
March 31, 2017 | -12.40M |
December 31, 2016 | -19.27M |
September 30, 2016 | -11.28M |
June 30, 2016 | -11.60M |
March 31, 2016 | -14.16M |
December 31, 2015 | -7.776M |
September 30, 2015 | -6.582M |
June 30, 2015 | -7.917M |
March 31, 2015 | -10.08M |
December 31, 2014 | -3.527M |
September 30, 2014 | -2.719M |
June 30, 2014 | -4.014M |
March 31, 2014 | -6.074M |
December 31, 2013 | -7.133M |
September 30, 2013 | -7.141M |
June 30, 2013 | -8.066M |
March 31, 2013 | -7.494M |
December 31, 2012 | -7.105M |
September 30, 2012 | -4.658M |
June 30, 2012 | -6.006M |
March 31, 2012 | -5.425M |
December 31, 2011 | -3.661M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-61.73M
Minimum
Jun 2022
-17.78M
Maximum
Sep 2023
-32.33M
Average
-29.11M
Median
Free Cash Flow (Quarterly) Benchmarks
Journey Medical Corp | -5.019M |
Avenue Therapeutics Inc | -3.12M |
Checkpoint Therapeutics Inc | -6.474M |
Mustang Bio Inc | -7.284M |
Viking Therapeutics Inc | -6.134M |